IRIS Accounts Production v24.3.2.46 12678422 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh126784222023-06-30126784222024-06-30126784222023-07-012024-06-30126784222022-06-30126784222022-07-012023-06-30126784222023-06-3012678422ns15:EnglandWales2023-07-012024-06-3012678422ns14:PoundSterling2023-07-012024-06-3012678422ns10:Director12023-07-012024-06-3012678422ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3012678422ns10:SmallEntities2023-07-012024-06-3012678422ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3012678422ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3012678422ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3012678422ns10:FullAccounts2023-07-012024-06-301267842212023-07-012024-06-3012678422ns10:Director22023-07-012024-06-3012678422ns10:RegisteredOffice2023-07-012024-06-3012678422ns5:CurrentFinancialInstruments2024-06-3012678422ns5:CurrentFinancialInstruments2023-06-3012678422ns5:Non-currentFinancialInstruments2024-06-3012678422ns5:Non-currentFinancialInstruments2023-06-3012678422ns5:ShareCapital2024-06-3012678422ns5:ShareCapital2023-06-3012678422ns5:RetainedEarningsAccumulatedLosses2024-06-3012678422ns5:RetainedEarningsAccumulatedLosses2023-06-3012678422ns5:NetGoodwill2023-07-012024-06-3012678422ns5:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3012678422ns5:FurnitureFittings2023-07-012024-06-3012678422ns5:MotorVehicles2023-07-012024-06-3012678422ns5:ComputerEquipment2023-07-012024-06-3012678422ns5:NetGoodwill2023-06-3012678422ns5:NetGoodwill2024-06-3012678422ns5:NetGoodwill2023-06-3012678422ns5:FurnitureFittings2023-06-3012678422ns5:MotorVehicles2023-06-3012678422ns5:ComputerEquipment2023-06-3012678422ns5:FurnitureFittings2024-06-3012678422ns5:MotorVehicles2024-06-3012678422ns5:ComputerEquipment2024-06-3012678422ns5:FurnitureFittings2023-06-3012678422ns5:MotorVehicles2023-06-3012678422ns5:ComputerEquipment2023-06-3012678422ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-06-3012678422ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-07-012024-06-3012678422ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-06-3012678422ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-06-3012678422ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3012678422ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3012678422ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-06-3012678422ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-06-3012678422ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-06-3012678422ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-06-3012678422ns5:HirePurchaseContracts2024-06-3012678422ns5:HirePurchaseContracts2023-06-3012678422ns5:WithinOneYear2024-06-3012678422ns5:WithinOneYear2023-06-3012678422ns5:BetweenOneFiveYears2024-06-3012678422ns5:BetweenOneFiveYears2023-06-3012678422ns5:MoreThanFiveYears2024-06-3012678422ns5:MoreThanFiveYears2023-06-3012678422ns5:AllPeriods2024-06-3012678422ns5:AllPeriods2023-06-3012678422ns5:Secured2024-06-3012678422ns5:Secured2023-06-30
REGISTERED NUMBER: 12678422 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

CINDERHILL PHARMACY LIMITED

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CINDERHILL PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTORS: M Mireku
E K D Odoom





REGISTERED OFFICE: 10 Broxtowe Lane
Nottingham
NG8 5NP





REGISTERED NUMBER: 12678422 (England and Wales)





ACCOUNTANTS: Crowe U.K. LLP
Black Country House
Rounds Green Road
Oldbury
West Midlands
B69 2DG

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

BALANCE SHEET
30 JUNE 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 337,049 386,374
Tangible assets 5 10,974 15,933
348,023 402,307

CURRENT ASSETS
Stocks 60,000 75,000
Debtors 6 159,171 132,849
Cash at bank and in hand 215,956 101,587
435,127 309,436
CREDITORS
Amounts falling due within one year 7 426,306 320,492
NET CURRENT ASSETS/(LIABILITIES) 8,821 (11,056 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

356,844

391,251

CREDITORS
Amounts falling due after more than
one year

8

370,010

398,708
NET LIABILITIES (13,166 ) (7,457 )

CAPITAL AND RESERVES
Called up share capital 6 6
Retained earnings (13,172 ) (7,463 )
(13,166 ) (7,457 )

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

BALANCE SHEET - continued
30 JUNE 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 March 2025 and were signed on its behalf by:





E K D Odoom - Director


CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024


1. STATUTORY INFORMATION

Cinderhill Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2021, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on reducing balance
Office equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2023 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 July 2023
and 30 June 2024 493,244
AMORTISATION
At 1 July 2023 106,870
Charge for year 49,325
At 30 June 2024 156,195
NET BOOK VALUE
At 30 June 2024 337,049
At 30 June 2023 386,374

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Office
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 July 2023 20,891 5,995 3,963 30,849
Additions 392 - 561 953
At 30 June 2024 21,283 5,995 4,524 31,802
DEPRECIATION
At 1 July 2023 8,949 2,763 3,204 14,916
Charge for year 4,237 808 867 5,912
At 30 June 2024 13,186 3,571 4,071 20,828
NET BOOK VALUE
At 30 June 2024 8,097 2,424 453 10,974
At 30 June 2023 11,942 3,232 759 15,933

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST
At 1 July 2023
and 30 June 2024 5,995
DEPRECIATION
At 1 July 2023 2,763
Charge for year 808
At 30 June 2024 3,571
NET BOOK VALUE
At 30 June 2024 2,424
At 30 June 2023 3,232

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 111,706 91,324
Other debtors 47,465 41,525
159,171 132,849

Included within other debtors is £3,898 (2023: £nil) due to MikeBen Properties Ltd, a company in which the Directors of this company are also Directors.

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank and other loans 126,831 29,049
Hire purchase contracts (see note 9)
1,012

1,349
Trade creditors 177,369 170,978
Taxation and social security 22,760 19,270
Other creditors 98,334 99,846
426,306 320,492

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2024 2023
£    £   
Bank loans 370,010 397,696
Hire purchase contracts (see note 9)
-

1,012
370,010 398,708

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 276,673 302,722

9. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2024 2023
£    £   
Net obligations repayable:
Within one year 1,012 1,349
Between one and five years - 1,012
1,012 2,361

Non-cancellable operating leases
2024 2023
£    £   
Within one year 16,750 16,750
Between one and five years 83,750 83,750
In more than five years 100,500 117,250
201,000 217,750

CINDERHILL PHARMACY LIMITED (REGISTERED NUMBER: 12678422)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


10. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Hire purchase contracts 1,012 2,361
Bank Loans 396,841 422,488
397,853 424,849

The bank loans are secured by fixed and floating charges over the assets of the company, and are shown within creditors.

The hire purchase loan is secured against the motor vehicle which is shown in tangible fixed assets.